Takeda Pharmaceutical
TAK
#457
Rank
A$79.48 B
Marketcap
A$24.89
Share price
1.38%
Change (1 day)
9.49%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2026 (TTM): A$0.66 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are A$29.73 Billion. In 2025 the company made an earning of A$4.69 Billion, an increase over its 2024 earnings that were of A$3.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.66 B-85.86%
2025 A$4.69 B49.03%
2024 A$3.15 B-2.41%
2023 A$3.22 B-28.14%
2022 A$4.49 B-40.9%
2021 A$7.60 B78.24%
2020 A$4.26 B246.1%
2019 A$1.23 B-48.79%
2018 A$2.40 B-23.64%
2017 A$3.15 B21.7%
2016 A$2.58 B-253.01%
2015 -A$1.7 Billion-159.65%
2014 A$2.83 B13%
2013 A$2.51 B2.46%
2012 A$2.44 B-57.05%
2011 A$5.70 B-10.49%
2010 A$6.37 B-3.99%
2009 A$6.63 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.67 B 9,308.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.28 B 5,616.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$14.95 B 3,735.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.82 B 3,190.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.81 B 2,673.61%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$18.56 B 4,663.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$14.13 B 3,525.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-A$1.12 Billion-386.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
A$0.93 B 140.37%๐Ÿ‡ฎ๐Ÿ‡ณ India